Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot arm meets virtual reality to train the Parkinson's brain

NCT ID NCT06920511

Symptom relief Sponsor: Fondazione Don Carlo Gnocchi ETS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are testing a rehabilitation platform called PRoBio that pairs a robotic arm with virtual reality and wearable sensors. The study enrolls 10 adults with mild Parkinson's disease and mild cognitive impairment. Participants take part in a four-week program with three weekly sessions of virtual cognitive training. The main goal is to see how usable and acceptable the system is for patients and therapists, and whether it can track body and stress signals during training.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A rehabilitation platform that combines a robotic arm with virtual reality and wearable sensors for cognitive training
What this could lead to
If it works well, this platform could offer a new way to deliver cognitive rehabilitation for people with Parkinson's disease and mild cognitive impairment.
What could go wrong
This is a small pilot study with 10 participants, so it can only show whether the system is usable and acceptable, not whether it improves thinking or memory. The results may not apply to a wider group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

May 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of mild Parkinson's Disease (Hoehn \& Yahr stage II-III); * Diagnosis of Mild Cognitive Impairment (MCI) according to Litvan et al. (2012) criteria for PD-MCI; * Age ≥ 18 years; * Signed informed consent Exclusion Criteria: * Diagnosis of Parkinson's Disease Dementia, atypical parkinsonisms, secondary parkinsonisms, or mixed forms; * Severe depressive syndrome * Absence of signed informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mild cognitive impairment (MCI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mild cognitive impairment (MCI) Parkinson desease

Contacts and locations

Locations

  • Fondazione Don Gnocchi

    Sant'Angelo dei Lombardi, Avellino, 83054, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.